Agree very much with what you say. It is fundamentals now - sales, revenue, profit and dividends.
I gather a lot of people think the SP will have a BIG JUMP in the next few weeks when validation happens and when some small sales occur. We now KNOW all this will happen - it will be NO BIG NEW NEWS. We will probably be lucky to be told of the sales. For sure we won't know who to and how much they pay.
Out side of this the only other news will be the POSSIBLE license agreement fees to pharmas for exclusive rights to certain classes of drugs. The pharmas will pay for the development of the specific reguirements - no big money in that to UNS.
Projected sales for 2011-2012 from Grif Report are $22M - that is something like 8-14M needles.
So the next 12 mths for me is a steady as she goes.
UNS Price at posting:
72.5¢ Sentiment: Hold Disclosure: Held
